Back to RecallTracker
Health Canada Health products

ARZERRA (ofatumumab) - Fatal Infusion Reaction Reported in a Patient with Chronic Lymphocytic Leukemia - For the Public

Issued August 6, 2014
Issue
Hazard description
Product safety